Literature DB >> 26361218

MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma.

Xiao Li1, Li Chen, Wei Wang, Fan-Bin Meng, Ren-Tao Zhao, Yang Chen.   

Abstract

miR-150 expression in osteosarcoma (OS) cell lines and human osteoblast cells was detected, and OS cell models were transfected with exogenous miR-150 to investigate its role in cell proliferation, invasion, and apoptosis. Our results showed that miR-150 expression in OS cells (MG63, Saos-2, SOSP-9607, and U2OS) was significantly lower compared to the osteoblast hFOB1.19 cell line (all p < 0.01). The expression level of miR-150 in MG63 cells that were transfected with exogenous miR-150 mimics was markedly upregulated, while the miR-150 expression level in the inhibitor group was significantly downregulated (both p < 0.01). Similar results were also found in SOSP-9607 cells. Importantly, exogenous miR-150 expression stimulated cell apoptosis and inhibited proliferation, invasion, and migration. A luciferase reporter assay displayed that miR-150 also regulated Sp1 expression by targeting its 3'-UTR, and qRT-PCR and Western blotting showed that elevated levels of miR-150 may reduce Sp1 protein expression. The mRNA and protein levels of Sp1 were upregulated after transfection with a Sp1-expression plasmid and partially reversed the inhibitory effects of miR-150 on cell proliferation, invasion, and metastasis in MG63 and SOSP-9607 cells, as well as promoted cell apoptosis. In conclusion, miR-150 inhibits cell proliferation, invasion, and metastasis and stimulates cell apoptosis by regulating the expression of Sp1. Therefore, miR-150 may be a potential clinical target for the treatment of OS patients.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26361218     DOI: 10.1159/000437379

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  11 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  Mir-150 Up-Regulates Glut1 and Increases Glycolysis in Osteosarcoma Cells

Authors:  Guangke Yuan; Yanqing Zhao; Dongjin Wu; Chunzheng Gao
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

3.  Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.

Authors:  Shingo Shimozaki; Norio Yamamoto; Takahiro Domoto; Hideji Nishida; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Kentaro Igarashi; Takashi Kato; Yu Aoki; Takashi Higuchi; Mayumi Hirose; Robert M Hoffman; Toshinari Minamoto; Hiroyuki Tsuchiya
Journal:  Oncotarget       Date:  2016-11-22

Review 4.  The Therapeutic Potential of MicroRNAs in Atrial Fibrillation.

Authors:  Xiaona Xu; Zhiqiang Zhao; Guangping Li
Journal:  Mediators Inflamm       Date:  2020-03-12       Impact factor: 4.711

5.  Retraction Note: MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.

Authors:  Bin Qiao; Bao-Xia He; Jing-Hua Cai; Qian Tao; Alfred King-Yin Lam
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

6.  MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1.

Authors:  Yang Qu; Su Pan; Mingyang Kang; Rongpeng Dong; Jianwu Zhao
Journal:  Tumour Biol       Date:  2015-11-11

7.  miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.

Authors:  Liangfeng Guo; Jianhui Yuan; Ni Xie; Huisheng Wu; Weicai Chen; Shufen Song; Xianming Wang
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

8.  MiR-150 Inhibits Cell Growth In Vitro and In Vivo by Restraining the RAB11A/WNT/β-Catenin Pathway in Thyroid Cancer.

Authors:  Dongfang Bai; Haipeng Sun; Xiaodong Wang; Hongliang Lou; Jian Zhang; Xiaohong Wang; Ling Jiang
Journal:  Med Sci Monit       Date:  2017-10-12

9.  Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.

Authors:  Lei Wang; Ailixiati Aireti; Aizezi Aihaiti; Kun Li
Journal:  Pathol Oncol Res       Date:  2018-09-15       Impact factor: 3.201

10.  MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2.

Authors:  Zhonghua Ling; Gentao Fan; Danhua Yao; Jianning Zhao; Yinhua Zhou; Jinzhu Feng; Guangxin Zhou; Yong Chen
Journal:  Exp Ther Med       Date:  2019-11-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.